Ablaze

THERAPEUTIC AREA

Oncology

YEAR INVESTED

2021

STAGE

Private

WEBSITE

www.ablazepharma.com ↗

Ablaze is a clinical-stage biotech company focused on developing Targeted Radiotherapy (TRT) treatments for cancer. Leveraging the founders' extensive expertise and cross-border networks, Ablaze drives innovative TRT products to the Chinese market, providing cancer patients in China with access to advanced therapeutic options.